Home/Filings/4/0001104659-26-002976
4//SEC Filing

MILLER MICHAEL PATRICK 4

Accession 0001104659-26-002976

CIK 0001720893other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 7:02 PM ET

Size

6.0 KB

Accession

0001104659-26-002976

Insider Transaction Report

Form 4
Period: 2026-01-09
Transactions
  • Award

    Stock Option (Right to Buy)

    [F1]
    2026-01-09+17,00017,000 total
    Exercise: $2.01Exp: 2036-01-09Common Stock (17,000 underlying)
Footnotes (1)
  • [F1]The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date.
Signature
/s/ Richard Steinhart, Attorney-in-Fact for Michael Patrick Miller|2026-01-12

Issuer

BioXcel Therapeutics, Inc.

CIK 0001720893

Entity typeother

Related Parties

1
  • filerCIK 0001236514

Filing Metadata

Form type
4
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 7:02 PM ET
Size
6.0 KB